Evidence map›Paper›PMID 28117699›Full record

ArticleMolecules (Basel, Switzerland)2017

Synthesis and Anticancer Activity of New 1-Thia-4-azaspiro[4.5]decane, Their Derived Thiazolopyrimidine and 1,3,4-Thiadiazole Thioglycosides.

Eman M Flefel, Wael A El-Sayed, Ashraf M Mohamed, Walaa I El-Sofany, Hanem M Awad

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eman M FlefelDepartment of Chemistry, College of Science, Taibah University, Al-Madinah Al-Monawarah 1343, Saudi Arabia. emanmflefel@yahoo.com.
Wael A El-SayedPhotochemistry Department, National Research Centre, Dokki 12622, Giza, Egypt. waelshendy@gmail.com.
Ashraf M MohamedApplied Organic Chemistry Department, National Research Centre, Dokki 12622, Giza, Egypt. ammewas1@gmail.com.
Walaa I El-SofanyPhotochemistry Department, National Research Centre, Dokki 12622, Giza, Egypt. walaa.elsofany@gmail.com.
Hanem M AwadDepartment of Tanning Materials and Leather Technology, National Research Centre, Dokki 12622, Giza, Egypt. hanem_awad@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New 1-thia-azaspiro[4.5]decane derivatives, their derived thiazolopyrimidine and 1,3,4-thiadiazole compounds were synthesized. The thioglycoside derivatives of the synthesized (1,3,4-thiadiazolyl)thiaazaspiro[4.5]decane and thiazolopyrimidinethione compounds were synthesized by glycosylation reactions using acetylated glycosyl bromides. The anticancer activity of synthesized compounds was studied against the cell culture of HepG-2 (human liver hepatocellular carcinoma), PC-3 (human prostate adenocarcinoma) and HCT116 (human colorectal carcinoma) cell lines and a number of compounds showed moderate to high inhibition activities.

Indexed as

Antineoplastic AgentsCarcinoma, HepatocellularCell Line, TumorColorectal NeoplasmsGlycosylationHCT116 CellsHep G2 CellsHumansLiver NeoplasmsMaleProstatic NeoplasmsSpiro CompoundsStructure-Activity RelationshipThiadiazolesThiazolidinesThioglycosides1,3,4-thiadiazoleAntineoplastic AgentsSpiro CompoundsThiadiazolesThiazolidinesThioglycosides1,3,4-thiadiazoles anticancer activity1-thia-azaspiro[4.5]decanethiazolopyrimidinethioglycosides

Identifiers

PMID28117699
PMCPMC6155784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.